T2期乳头状甲状腺癌:甲状腺腺叶切除不足以替代全甲状腺切除
该研究基于美国国家癌症数据库2004-2008年33,816例1.0-3.9 cm、临床淋巴结阴性的成人乳头状甲状腺癌手术病例,按肿瘤大小分层分析手术范围对总生存的影响。结果显示,对于2.0-3.9 cm经典型乳头状甲状腺癌,全甲状腺切除与生存改善相关(P=0.03),而滤泡变异型各大小亚组中腺叶切除与全切除生存相当。
要点
- 2.0-3.9 cm经典型乳头状甲状腺癌,全甲状腺切除与生存改善相关(P=0.03)。
- 1.0-1.9 cm经典型乳头状甲状腺癌,全切除与腺叶切除生存差异无统计学意义(P=0.16)。
- 滤泡变异型1.0-3.9 cm肿瘤,腺叶切除与全甲状腺切除生存相当。
核心结论
- 肿瘤大小、组织学亚型和手术方式均是乳头状甲状腺癌生存的重要影响因素。
- 对于2.0-3.9 cm经典型乳头状甲状腺癌,全甲状腺切除与生存改善相关,应考虑行全甲状腺切除。
- 当术前分子检测未用于区分经典型与滤泡变异型时,2.0-3.9 cm乳头状甲状腺癌应倾向考虑全甲状腺切除。
研究设计与样本
- 基于美国国家癌症数据库(National Cancer Data Base)的回顾性队列研究。
- 纳入2004至2008年接受手术的33,816例成人乳头状甲状腺癌患者,肿瘤大小1.0-3.9 cm且临床淋巴结阴性。
- 将经典型与滤泡变异型乳头状甲状腺癌分为两组,采用按肿瘤大小分层的Cox回归模型分析手术范围对总生存的影响。
主要发现
- 全组30,981例行全甲状腺切除,2,835例行甲状腺腺叶切除;经典型22,899例,滤泡变异型10,918例。
- 未调整KM分析中,全甲状腺切除与经典型患者生存改善相关(P=0.02),滤泡变异型患者中未观察到生存差异(P=0.42)。
- 调整分析中,经典型2.0-3.9 cm肿瘤全甲状腺切除与生存改善相关(P=0.03),1.0-1.9 cm肿瘤无统计学差异(P=0.16)。
- 滤泡变异型1.0-1.9 cm(P=0.45)和2.0-3.9 cm(P=0.88)肿瘤中,腺叶切除与全甲状腺切除生存相当。
临床怎么用
- 对2.0-3.9 cm经典型乳头状甲状腺癌,应优先考虑全甲状腺切除而非腺叶切除。
- 若术前未通过分子检测区分经典型与滤泡变异型,2.0-3.9 cm乳头状甲状腺癌应按经典型处理,考虑全甲状腺切除。
- 对滤泡变异型1.0-3.9 cm乳头状甲状腺癌,腺叶切除可作为与全甲状腺切除生存相当的选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Histologic subtypes of papillary thyroid cancer affect prognosis. The objective of this study was to examine whether survival is affected by extent of surgery for conventional versus follicular-variant papillary thyroid cancer when stratified by tumor size. METHODS: Using the National Cancer Data Base, we evaluated 33,816 adults undergoing surgery for papillary thyroid cancer from 2004 to 2008 for 1.0-3.9 cm tumors and clinically negative lymph nodes. Conventional and follicular-variant papillary thyroid cancers were divided into separate groups. Cox regression models stratified by tumor size were used to determine if extent of surgery affected overall survival. RESULTS: A total of 30,981 patients had total thyroidectomy and 2,835 had thyroid lobectomy; 22,899 patients had conventional papillary thyroid cancer and 10,918 had follicular-variant papillary thyroid cancer. On unadjusted KM analysis, total thyroidectomy was associated with improved survival for conventional (P = 0.02) but not for follicular-variant papillary thyroid cancer patients (P = 0.42). For conventional papillary thyroid cancer, adjusted analysis showed total thyroidectomy was associated with improved survival for 2.0-3.9 cm tumors (P = 0.03) but not for 1.0-1.9 cm tumors (P = 0.16). For follicular-variant, lobectomy and total thyroidectomy had equivalent survival for 1.0-1.9 cm (P = 0.45) and 2.0-3.9 cm (P = 0.88) tumors. CONCLUSION: Tumor size, histologic subtype, and surgical therapy are important factors in papillary thyroid cancer survival. Total thyroidectomy was associated with improved survival in patients with 2.0-3.9 cm conventional papillary thyroid cancer, and should be considered for 2.0-3.9 cm papillary thyroid cancers when preoperative molecular analysis is not used to distinguish conventional from follicular-variant.
引用
- Rajjoub SR, Yan H, Calcatera NA, et al. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers. Surgery. 2018. PMID: 29426618. doi:10.1016/j.surg.2017.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。